Exact Mass: 508.2758
Exact Mass Matches: 508.2758
Found 500 metabolites which its exact mass value is equals to given mass value 508.2758
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPG(18:2(9Z,12Z)/0:0)
LysoPG(18:2(9Z,12Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:2(9Z,12Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position.
Calcitriol phosphate
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide
5beta-acetoxy-4beta,11-diangeloyloxy-8,10-dihydroxy-2beta,3beta-epoxy-bisabol-7(14)-ene
1beta,2beta,3beta,4beta,5beta,7alpha-hexahydroxy-spirost-25(27)-en-6-one
methyl 15,16-dideoxy-6alpha,15alpha,17beta-trihydroxy-15,17-oxidospongian-16-carboxylate 6,15,17-triacetate
2beta-acetoxy-1beta,8-diangeloyloxy-3beta,4beta-epoxy-10,11-dihydroxybisabol-7(14)-ene|4beta-acetoxy-5beta,8-diangeloyloxy-10,11-dihydroxy-2beta,3beta-epoxy-bisabol-7(14)-ene
3beta-angeloyloxy-9beta-acetoxy-8beta-angeloyloxy-4alpha,5alpha-dihydroxy-1beta,10alpha-epoxygermacr-11-ene
pregn-5-ene-3,14-beta-dihydroxy-7,20-dione 3-O-beta-glucopyranoside
(3S,5R,6S,9R)-megastigman-3,9-diol 3-O-alpha-L-arabinofuranosyl-(1?6)-b-D-glucopyranoside
(2S,3aS)-5-(1-hydroxy-3-(4-methoxyphenyl)propylidene)-2-(2-hydroxypropan-2-yl)-3a,7-bis(3-methylbut-2-en-1-yl)tetrahydrobenzofuran-4,6(2H,5H)-dione|Flemiphilippinone A
1beta-acetoxy-2beta,8-diangloyloxy-10,11-dihydroxy-3,4-epoxybisabol-7(14)-ene
(3S,5R,6S,9S)-megastigmane-3,9-diol 3-O-beta-D-(6-O-beta-D-apiofuranosyl)glucopyranoside|oblongionoside C
14beta-hydroxy-15alpha-(beta-D-glucopyranosyloxy)-17betaH-pregn-4-ene-3,20-dione|stemmoside B
5beta-acetoxy-4beta,10-diangeloyloxy-8,11-dihydroxy-2beta,3beta-epoxy-bisabol-7(14)-ene
3beta-angeloyloxy-9beta-acetoxy-8beta-senecioyloxy-4alpha,5alpha-dihydroxy-1beta,10alpha-epoxygermacr-11-ene
cyclo(N8-(alpha,alpha-dimethylallyl)-L-Trp-6a-(alpha,alpha-dimethylallyl)-L-Trp)
Ajugamarin B3|ajugamarin B3 ((12S)-19-acetoxy-6alpha,12-dihydroxy-1beta-<(2S)-2-methylbutanoyloxy>-4,18-epoxyneo-clerod-13(14)-en-15,16-olide)|ajugamarin B3 [(12S)-19-acetoxy-6alpha,12-dihydroxy-1beta-((2S)-2-methylbutanoyloxy)-4,18-epoxyneo-clerod-13(14)-en-15,16-olide]
21-O-beta-D-Glucosyl-14,21-dihydroxy-14beta-pregn-4-ene-3,20-dione
Phe Thr Asn Lys
Phe Asn Thr Lys
Asn Thr Phe Lys
2,5-Piperazinedione, 3-[[1-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-6-[[2-(1,1-dimethyl-2-propen-1-yl)-1H-indol-3-yl]methyl]-, (3S,6S)_120157
C32H36N4O2_8a,16a-Bis(2-methyl-3-buten-2-yl)-5a,8,8a,13,13a,15a,16,16a-octahydroindolo[3,2:4,5]pyrrolo[1,2:4,5]pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-7,15(5H,7aH)-dione
(2E,4E)-1-[(2R,6S,14S,22S,25R)-25-(3,3-dimethyloxiran-2-yl)-15-methyl-1,3,13,15-tetraazaheptacyclo[18.4.1.0²,⁶.0⁶,²².0⁷,¹².0¹⁴,²².0¹⁶,²¹]pentacosa-7,9,11,16(21),17,19-hexaen-3-yl]hexa-2,4-dien-1-one
Ala Lys Gln Tyr
Ala Lys Tyr Gln
Ala Gln Lys Tyr
Ala Gln Tyr Lys
Ala Tyr Lys Gln
Ala Tyr Gln Lys
Asp Ile Val Tyr
Phe Phe Pro Val
Phe Phe Val Pro
Phe Ile Met Val
Phe Ile Val Met
Phe Lys Asn Thr
Phe Lys Gln Ser
Phe Lys Ser Gln
Phe Lys Thr Asn
Phe Leu Met Val
Phe Leu Val Met
Phe Met Ile Val
Phe Met Leu Val
Phe Met Val Ile
Phe Met Val Leu
Phe Asn Lys Thr
Phe Pro Phe Val
Phe Pro Val Phe
Phe Gln Lys Ser
Phe Gln Ser Lys
Phe Ser Lys Gln
Phe Ser Gln Lys
Phe Thr Lys Asn
Phe Val Phe Pro
Phe Val Ile Met
Phe Val Leu Met
Phe Val Met Ile
Phe Val Met Leu
Phe Val Pro Phe
His Lys Pro Gln
His Lys Gln Pro
His Pro Lys Gln
His Pro Gln Lys
His Gln Lys Pro
His Gln Pro Lys
Ile Phe Met Val
Ile Phe Val Met
Ile Ile Thr Tyr
Ile Ile Tyr Thr
Ile Leu Thr Tyr
Ile Leu Tyr Thr
Ile Met Phe Val
Ile Met Val Phe
Ile Thr Ile Tyr
Ile Thr Leu Tyr
Ile Thr Tyr Ile
Ile Thr Tyr Leu
Ile Val Phe Met
Ile Val Met Phe
Ile Tyr Ile Thr
Ile Tyr Leu Thr
Ile Tyr Thr Ile
Ile Tyr Thr Leu
Lys Ala Gln Tyr
Lys Ala Tyr Gln
Lys Phe Asn Thr
Lys Phe Gln Ser
Lys Phe Ser Gln
Lys Phe Thr Asn
Lys His Pro Gln
Lys His Gln Pro
Lys Asn Phe Thr
Lys Asn Thr Phe
Lys Pro His Gln
Lys Pro Gln His
Lys Gln Ala Tyr
Lys Gln Phe Ser
Lys Gln His Pro
Lys Gln Pro His
Lys Gln Ser Phe
Lys Gln Tyr Ala
Lys Ser Phe Gln
Lys Ser Gln Phe
Lys Thr Phe Asn
Lys Thr Asn Phe
Lys Tyr Ala Gln
Lys Tyr Gln Ala
Leu Phe Glu Thr
Leu Phe Met Val
Leu Phe Thr Glu
Leu Phe Val Met
Leu Ile Thr Tyr
Leu Ile Tyr Thr
Leu Leu Thr Tyr
Leu Leu Tyr Thr
Leu Met Phe Val
Leu Met Val Phe
Leu Thr Glu Phe
Leu Thr Phe Glu
Leu Thr Ile Tyr
Leu Thr Leu Tyr
Leu Thr Tyr Ile
Leu Thr Tyr Leu
Leu Val Asp Tyr
Leu Val Phe Met
Leu Val Met Phe
Leu Val Tyr Asp
Leu Tyr Asp Val
Leu Tyr Ile Thr
Leu Tyr Leu Thr
Leu Tyr Thr Ile
Leu Tyr Thr Leu
Leu Tyr Val Asp
Met Phe Ile Val
Met Phe Leu Val
Met Phe Val Ile
Met Phe Val Leu
Met Ile Phe Val
Met Ile Val Phe
Met Leu Phe Val
Met Leu Val Phe
Met Val Phe Ile
Met Val Phe Leu
Met Val Ile Phe
Met Val Leu Phe
Asn Phe Lys Thr
Asn Phe Thr Lys
Asn Lys Phe Thr
Asn Lys Thr Phe
Asn Thr Lys Phe
Pro Phe Phe Val
Pro Phe Val Phe
Pro His Lys Gln
Pro His Gln Lys
Pro Lys His Gln
Pro Lys Gln His
Pro Gln His Lys
Pro Gln Lys His
Pro Val Phe Phe
Gln Ala Lys Tyr
Gln Ala Tyr Lys
Gln Phe Lys Ser
Gln Phe Ser Lys
Gln His Lys Pro
Gln His Pro Lys
Gln Lys Ala Tyr
Gln Lys Phe Ser
Gln Lys His Pro
Gln Lys Pro His
Gln Lys Ser Phe
Gln Lys Tyr Ala
Gln Pro His Lys
Gln Pro Lys His
Gln Ser Phe Lys
Gln Ser Lys Phe
Gln Tyr Ala Lys
Gln Tyr Lys Ala
Ser Phe Lys Gln
Ser Phe Gln Lys
Ser Lys Phe Gln
Ser Lys Gln Phe
Ser Gln Phe Lys
Ser Gln Lys Phe
Thr Glu Phe Ile
Thr Glu Phe Leu
Thr Glu Ile Phe
Thr Glu Leu Phe
Thr Phe Glu Ile
Thr Phe Glu Leu
Thr Phe Ile Glu
Thr Phe Lys Asn
Thr Phe Leu Glu
Thr Phe Asn Lys
Thr Ile Glu Phe
Thr Ile Phe Glu
Thr Ile Ile Tyr
Thr Ile Leu Tyr
Thr Ile Tyr Ile
Thr Ile Tyr Leu
Thr Lys Phe Asn
Thr Lys Asn Phe
Thr Leu Glu Phe
Thr Leu Phe Glu
Thr Leu Ile Tyr
Thr Leu Leu Tyr
Thr Leu Tyr Ile
Thr Leu Tyr Leu
Thr Asn Phe Lys
Thr Asn Lys Phe
Thr Tyr Ile Ile
Thr Tyr Ile Leu
Thr Tyr Leu Ile
Thr Tyr Leu Leu
Val Asp Ile Tyr
Val Asp Leu Tyr
Val Asp Tyr Ile
Val Asp Tyr Leu
Val Glu Val Tyr
Val Glu Tyr Val
Val Phe Phe Pro
Val Phe Ile Met
Val Phe Leu Met
Val Phe Met Ile
Val Phe Met Leu
Val Phe Pro Phe
Val Ile Asp Tyr
Val Ile Phe Met
Val Ile Met Phe
Val Ile Tyr Asp
Val Leu Asp Tyr
Val Leu Phe Met
Val Leu Met Phe
Val Leu Tyr Asp
Val Met Phe Ile
Val Met Phe Leu
Val Met Ile Phe
Val Met Leu Phe
Val Pro Phe Phe
Val Val Glu Tyr
Val Val Tyr Glu
Val Tyr Asp Ile
Val Tyr Asp Leu
Val Tyr Glu Val
Val Tyr Ile Asp
Val Tyr Leu Asp
Val Tyr Val Glu
Tyr Ala Lys Gln
Tyr Ala Gln Lys
Tyr Asp Ile Val
Tyr Asp Leu Val
Tyr Asp Val Ile
Tyr Asp Val Leu
Tyr Ile Asp Val
Tyr Ile Ile Thr
Tyr Ile Leu Thr
Tyr Ile Thr Ile
Tyr Ile Thr Leu
Tyr Ile Val Asp
Tyr Lys Ala Gln
Tyr Lys Gln Ala
Tyr Leu Asp Val
Tyr Leu Ile Thr
Tyr Leu Leu Thr
Tyr Leu Thr Ile
Tyr Leu Thr Leu
Tyr Leu Val Asp
Tyr Gln Ala Lys
Tyr Gln Lys Ala
Tyr Thr Ile Ile
Tyr Thr Ile Leu
Tyr Thr Leu Ile
Tyr Thr Leu Leu
Tyr Val Asp Ile
Tyr Val Asp Leu
Tyr Val Glu Val
Tyr Val Ile Asp
Tyr Val Leu Asp
Tyr Val Val Glu
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3 / 26,26,26,27,27,27-hexafluoro-25-hydroxycholecalciferol
glas#20
An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#20 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.
26,26,26,27,27,27-hexafluoro-1alphaa-hydroxyvitamin D3
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D3
(2-Butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone
Sodium 2,2-methylene-bis-(4,6-di-tert-butylphenyl)phosphate
1-O-{(11R)-11-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dodecanoyl}-beta-D-glucopyranose
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide
(5Z)-5-[(2E)-2-[2-(6-hydroxy-6-methylheptan-2-yl)-3-methyl-11-oxo-10,12,13-trioxa-11lambda5-phosphatetracyclo[9.1.1.01,9.03,8]tridecan-7-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
2-(1,1-Dimethyl-2-propenyl)cyclo[L-Trp-2-(1,1-dimethyl-2-propenyl)-L-Trp-]
(3S)-3alpha-[1-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6alpha-[2-(1,1-dimethyl-2-propenyl)-1H-indole-3-ylmethyl]piperazine-2,5-dione
1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-Hexadecanoyl-2-(5-hydroxypentanoyl)-sn-phosphatidate(2-)
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methyl-3-(1-naphthalenyl)urea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(2-methoxyphenyl)-1-methylurea
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-pyridin-4-ylacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-piperidin-1-ylethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2S)-1-hydroxypropan-2-yl]-1-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
3-(4-fluorophenyl)-1-[(2R)-1-hydroxypropan-2-yl]-1-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-[[4-(2-pyridinyl)phenyl]methyl]amino]butyl]urea
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z)-octadeca-9,12-dienoate
1-(9Z,12Z-octadecadienoyl)-glycero-3-phospho-(1-sn-glycerol)
MCP110
MCP110 is an inhibitor of Ras/Raf-1 interaction. MCP110 blocks the interaction of Ras with Raf. MCP110 disrupts this interaction might can be used for the research of human tumors[1].